Personal Injury
Green, Schafle & Gibbs
More Generic Zantac Recalls Over Possible ...

Recalls of generic Zantac believed to be contaminated by a carcinogen continue to flood in. Two other firms have declared recalls of ranitidine heartburn meds in 150 mg and 300 mg doses. The news arrived even as the degree of the drug returns increased with Mylan’s impromptu recall of three lots of nizatidine capsules last week because the API in them also held dangerous levels of NDMA.

More Generic Zantac Recalls Over Possible Contamination
Personal Injury
Green, Schafle & Gibbs
Why Companies Recalled Heartburn Medications

Shortly after the Federal officials announced the voluntary recalls of some pharmacies over NDMA, a drug filled with a potential human carcinogen, many other pharmacies have recalled the common variety of heartburn drug Zantac, called ranitidine, from shelves.

Why Companies Recalled Heartburn Medications
Personal Injury
Green, Schafle & Gibbs
Zantac Generics Recall Grows Due to Cancer Risk

Additional generic editions of Zantac are being taken down from pharmacy shelves after officials detected low levels of a possible carcinogens in the heartburn medication.

Zantac Generics Recall Grows Due to Cancer Risk
Personal Injury
Green, Schafle & Gibbs
Stryker Hip Implant Failures

The Stryker Tritanium Acetabular Shell, which restores the human hip socket, is built from a titanium alloy covered with a unique kind of porous foam. The foam enables bone cells to bind with it and grow, thereby increasing joint stability. However, a 2018 report in the journal Arthroplasty Today by doctors at NYU Langone Orthopedic Hospitals described five hip implant failures related to Stryker’s Tritanium cups between 2011 and 2016.

Stryker Hip Implant Failures
Personal Injury
Green, Schafle & Gibbs
Stryker Recalls Femoral Head Implants

Medical technology giant, Stryker Corporation, has issued an urgent voluntary recall of its femoral head implants due to evidence that they may cause serious medical issues.

Stryker Recalls Femoral Head Implants

nursing home neglect

Nursing Home Abuse and Neglect Controversy

Nursing Home Abuse and Neglect Controversy

According a recent Philadelphia Inquirer article, lawmakers insist that enough nursing homes receiving government subsidies or support remain understaffed, thus increasing profit at the expense of care, to justify subpoenas, investigations, and litigation. The nursing home industry vehemently disagrees, and they have found their own lawyers to drive their point home.

FIRM LOCATION:

PHILADELPHIA

2332 South Broad Street

Philadelphia PA 19145

p: 215 462 3330 / f: 215-567-1941